mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-06 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |